Dalriada Therapeutics Won the FACIT Prospect Fund Award

February 6, 2018

Dalriada Therapeutics, Professor Gunning’s start-up company, won the Fight Against Cancer Innovation Trust (FACIT) Prospect Fund Award.

 

 

 

Please reload

Featured Posts

Congrats Murtaza on Publishing the Tetris-based approach to targeting HDAC8

July 30, 2020

1/3
Please reload

Recent Posts
Please reload

Archive
Please reload

Search By Tags

I'm busy working on my blog posts. Watch this space!

Please reload

Follow Us
  • Facebook Basic Square
  • Twitter Basic Square
  • Google+ Basic Square

UNIVERSITY OF TORONTO MISSISSAUGA

GUNNING GROUP © 2020

CONTACT US

  • White LinkedIn Icon
  • White Twitter Icon